The TransQST Webinar series 2020 resumed on Monday September 14th with a presentation delivered by the Senior Director of OcellO BV, Bram Herpers, on the use of organoids in drug testing.
OcellO is a CRO offering drug testing services in 3D cultured human tissues. OcellO screens, identifies and profiles potential drugs for efficacy and adverse effects for various indications, including oncology, immuno-oncology, cystic fibrosis and polycystic kidney disease, helping customers to discover the full potential of their compounds.
The webinar provided a concrete demonstration of the use of OcellO’s image-based analysis platform to evaluate compound efficacy and adversity in gastrointestinal human organoids for an audience of over 50 TransQST delegates and external guests.